ACG Wealth’s Zimmer Biomet ZBH Stock Holding History

ACG Wealth’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-968	Closed	-$102K	–	1043
2022 Q2	$102K	Buy	+968	New	+$115K	0.02%	330

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

ACG Wealth's ZBH Position: Q3 2022 in Review

ACG Wealth sold out of Zimmer Biomet (ZBH) in Q3 2022, closing a stake of 968 shares — an estimated $102K sold.

ACG Wealth first reported a position in ZBH in Q2 2022 and held it in 1 quarter. The position peaked at $102K in Q2 2022. 919 funds tracked by Wall St. Rank hold ZBH as of Q3 2022.

ACG Wealth reported no remaining Zimmer Biomet position as of Q3 2022 after selling out during the quarter.
ACG Wealth sold 968 Zimmer Biomet shares in Q3 2022, an estimated $102K.
ACG Wealth first reported a position in Zimmer Biomet in Q2 2022 and held it in 1 quarter.
ACG Wealth's Zimmer Biomet position peaked at $102K in Q2 2022.
919 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2022.

Based on ACG Wealth's 13F filing for Q3 2022, filed 3 Nov 2022.